205 related articles for article (PubMed ID: 22119775)
1. Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli.
Dang S; Hong T; Bu D; Tang J; Fan J; Zhang W
Protein Expr Purif; 2012 Mar; 82(1):32-6. PubMed ID: 22119775
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli.
Bu D; Zhou Y; Tang J; Jing F; Zhang W
Protein Expr Purif; 2013 Dec; 92(2):203-7. PubMed ID: 24128692
[TBL] [Abstract][Full Text] [Related]
3. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
4. A polyclonal antibody against active C-terminal ADAMTS-18 fragment.
Dang S; Bu D; Hong T; Zhang W
Hybridoma (Larchmt); 2011 Dec; 30(6):567-9. PubMed ID: 22149285
[TBL] [Abstract][Full Text] [Related]
5. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
7. Optimization of dilution refolding conditions for a camelid single domain antibody against human beta-2-microglobulin.
Bao X; Xu L; Lu X; Jia L
Protein Expr Purif; 2016 Jan; 117():59-66. PubMed ID: 26386406
[TBL] [Abstract][Full Text] [Related]
8. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
Upadhyay V; Singh A; Panda AK
Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
Wan L; Zeng L; Chen L; Huang Q; Li S; Lu Y; Li Y; Cheng J; Lu X
Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
[TBL] [Abstract][Full Text] [Related]
10. Production and purification of refolded recombinant human IL-7 from inclusion bodies.
Ouellette T; Destrau S; Ouellette T; Zhu J; Roach JM; Coffman JD; Hecht T; Lynch JE; Giardina SL
Protein Expr Purif; 2003 Aug; 30(2):156-66. PubMed ID: 12880763
[TBL] [Abstract][Full Text] [Related]
11. Integrated refolding techniques for Schistosoma japonicum MTH1 overexpressed as inclusion bodies in Escherichia coli.
Feng Y; Liu L; Wang J; Liu J; Hu W; Wang X; Yang Z
Protein Expr Purif; 2012 Aug; 84(2):181-7. PubMed ID: 22641057
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
[TBL] [Abstract][Full Text] [Related]
13. Expression, refolding and purification of a human interleukin-17A variant.
Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli.
Khan RH; Rao KB; Eshwari AN; Totey SM; Panda AK
Biotechnol Prog; 1998; 14(5):722-8. PubMed ID: 9758661
[TBL] [Abstract][Full Text] [Related]
15. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli.
Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG
Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
[TBL] [Abstract][Full Text] [Related]
17. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
18. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
[TBL] [Abstract][Full Text] [Related]
19. A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active Oligomers.
Kosasih HJ; Last K; Rogerson FM; Golub SB; Gauci SJ; Russo VC; Stanton H; Wilson R; Lamande SR; Holden P; Fosang AJ
J Biol Chem; 2016 Feb; 291(7):3197-208. PubMed ID: 26668318
[TBL] [Abstract][Full Text] [Related]
20. Single pH buffer refolding screen for protein from inclusion bodies.
Coutard B; Danchin EG; Oubelaid R; Canard B; Bignon C
Protein Expr Purif; 2012 Apr; 82(2):352-9. PubMed ID: 22343064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
